Clonogenicity of circulating neuroblastoma cells: implications regarding peripheral blood stem cell transplantation

TJ Moss(Cedars-Sinai Medical Center), Bruce Bostrom(Minnesota West Community & Technical College), Mitchell S. Cairo(New York Medical College), Joel Weinthal, C. Hurvitz(Cedars-Sinai Medical Center), VM Santana(Cedars-Sinai Medical Center)

Blood

May 15, 1994

10.1182/blood.v83.10.3085.3085

Cited by 81

Related Papers

Guidelines for the Management of Pediatric and Adult Tumor Lysis Syndrome: An Evidence-Based Review

|Journal of Clinical Oncology|2008|794

A randomized comparison of nativeEscherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study

|Blood|2002|496

Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients

|Blood|2006|431

Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents

|Blood|2006|362

Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group

|Blood|2003|361